Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1996
05/07/1996US5514787 DNA sequences encoding human membrane cofactor protein (MCP)
05/07/1996US5514786 Compositions for inhibiting RNA activity
05/07/1996US5514781 Use of azoles as virucidal agents in solutions of biologically active proteins
05/07/1996US5514780 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products
05/07/1996US5514779 Chitinases, fungicides
05/07/1996US5514778 Anti-picornaviral agents
05/07/1996US5514777 Methods of synthesis of peptidyl argininals
05/07/1996US5514776 Antiallergen
05/07/1996US5514775 Chromogranin peptides
05/07/1996US5514774 Conotoxin peptides
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514714 Methods and polycyclic aromatic compound containing compositions for treating T-cell-mediated diseases
05/07/1996US5514694 Peptidyl ketoamides
05/07/1996US5514683 Bicyclo 2,2,2!octane derivatives
05/07/1996US5514676 Amino-benzoic acids and derivatives, and methods of use
05/07/1996US5514670 Submicron emulsions for delivery of peptides
05/07/1996US5514660 Method for treating and inhibiting gastric and duodenal ulcers
05/07/1996US5514657 Wound healing, silver sulfadiazine, collagen
05/07/1996US5514656 Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
05/07/1996US5514655 Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
05/07/1996US5514654 N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
05/07/1996US5514653 Serpin-enzyme complex, treatment of alzheimer*s disease, inhibitor peptide
05/07/1996US5514652 Therapy of respiratory tract diseases using basic fibroblast growth factor
05/07/1996US5514651 Aza cyclohexapeptide compounds
05/07/1996US5514650 Pneumocystis fungicide
05/07/1996US5514649 Animal growth regulators; treating gramnegative and grampositive bacterial infections
05/07/1996US5514648 Fungicidally active compounds
05/07/1996US5514647 Fibronectin-containing ophthalmic solution, method of preserving an opthalmic solution, and methods of treatment of opthalmic wounds
05/07/1996US5514646 Insulin analogs modified at position 29 of the B chain
05/07/1996US5514591 Method for measuring the ability of a yeast cell extract to influence oxygen respiration
05/07/1996US5514582 Recombinant DNA encoding hybrid immunoglobulins
05/07/1996US5514579 Human transglutaminases
05/07/1996US5514578 Genetic engineering
05/07/1996US5514577 Oligonucleotide therapies for modulating the effects of herpes viruses
05/07/1996US5514571 Cyclin D1 negative regulatory activity
05/07/1996US5514566 Methods of producing recombinant fibroblast growth factors
05/07/1996US5514565 Enzymatically-produced dimeric IL-2 and a nerve-derived transglutaminase enzyme for its preparation
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/07/1996US5514554 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
05/07/1996US5514536 Solutions for tissue preservation and bloodless surgery and methods using same
05/07/1996US5514409 Methods for coating invasive devices with inhibitors of thrombin
05/07/1996US5514373 Topical preparation
05/07/1996US5514370 High dosage topical forms of collagenase
05/07/1996US5514365 Pharmaceutical compositions comprising calcitonin for intranasal administration
05/07/1996CA2025317C Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
05/07/1996CA2000283C Proteinaceous composition
05/07/1996CA1338319C Cyclosporin derivative with modified "8-amino acid"
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012955A1 METHOD FOR INCREASING THE RESISTANCE OF NEURAL CELLS TO β-AMYLOID PEPTIDE TOXICITY
05/02/1996WO1996012823A1 Cloned transcription factor regulating mhc expression
05/02/1996WO1996012811A2 Yeast telomerase components and methods using them
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012807A2 Hepatitis e virus antigens and uses therefor
05/02/1996WO1996012806A1 Calcineurin interacting protein compositions and methods
05/02/1996WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor
05/02/1996WO1996012803A1 Method for the ex vivo treatment of tumour cells from patients with cml
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012800A1 Modified factor vii
05/02/1996WO1996012799A1 Neutralization of foof allergens by thioredoxin
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012791A1 Human abh
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012740A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY
05/02/1996WO1996012739A1 Immunomodulatory polypeptides
05/02/1996WO1996012738A2 Pepstatin-derivatives for the treatment and detection of fungal infections
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996WO1996012736A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY
05/02/1996WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996WO1996012732A1 Novel peptide and therapeutic agent
05/02/1996WO1996012731A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996WO1996012508A2 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy
05/02/1996WO1996012506A1 Senescent cell-derived inhibitors of dna synthesis
05/02/1996WO1996012505A1 Conjugates of a polypeptide or oligopeptide with a low molecular weight lipophilic compound
05/02/1996WO1996012503A1 Remedy for diseases caused by il-6 production
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012500A1 INTERFERON-η TREATMENT OF HLA-DR-ASSOCIATED IMMUNODEFICIENCY
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996WO1996012482A1 Hydroxyethyl aminimides
05/02/1996WO1996012475A1 Active agent transport systems
05/02/1996WO1996012474A1 Compositions for the delivery of antigens
05/02/1996WO1996012473A1 Compounds and compositions for delivering active agents
05/02/1996WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
05/02/1996WO1996006633A3 Methods of inducing hair growth and coloration
05/02/1996WO1996004011A3 Novel compound to mimic a naturally occurring peptide's effect
05/02/1996WO1996003435A3 FELINE η-INTERFERON
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1995034571A3 Drug salts
05/02/1996WO1995027732A3 Circularly permuted ligands and circularly permuted chimeric molecules
05/02/1996WO1994025604A3 Steroid 21-hydroxylase fragments and assays using the same
05/02/1996DE19500394A1 Peptide zur Diagnose, zum Nachweis und zur Prävention von Hepatitis C Virus (HCV)-Infektionen Peptides for diagnosis, for the detection and prevention of hepatitis C virus (HCV) infections
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2416318A1 Soluble, recombinant botulinum toxin proteins
05/02/1996CA2203825A1 Compounds and methods for inhibiting beta-protein filament formation and neurotoxicity
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
1 ... 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 ... 3163